# Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

> **NCT00483054** · PHASE3 · COMPLETED · sponsor: **Bamrasnaradura Infectious Diseases Institute** · enrollment: 142 (actual)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** efavirenz
- **DRUG:** nevirapine

## Key facts

- **NCT ID:** NCT00483054
- **Lead sponsor:** Bamrasnaradura Infectious Diseases Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-12
- **Final completion:** 2010-12
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2011-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483054, "Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00483054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*